0

Irbesartan Related Compound A

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP748812535
CAS748812-53-5
Structure
MDL NumberMFCD22380598
Molecular Weight446.54
InChI KeyPAKGYCNZUGIDHV-UHFFFAOYSA-N
DescriptionUnited States Pharmacopeia (USP) Reference Standard
Formneat
Gradepharmaceutical primary standard
Size25MG
1

Carnosic Acid Improves Diabetic Nephropathy by Activating Nrf2/ARE and Inhibition of NF-κB Pathway

Zhisheng Xie, Lingjun Zhong, Yanrao Wu, Xiaomeng Wan, Hua Yang, Xiaojun Xu, Ping Li

Phytomedicine. 2018 Aug 1;47:161-173.

PMID: 30166101

1

Peptide and Nonpeptide Antagonist Interaction With Constitutively Active Human AT1 Receptors

Minh Tam Le, Patrick M L Vanderheyden, Márta Szaszák, László Hunyady, Veerle Kersemans, Georges Vauquelin

Biochem Pharmacol. 2003 Apr 15;65(8):1329-38.

PMID: 12694873

1

Sorption of Citalopram, Irbesartan and Fexofenadine in Soils: Estimation of Sorption Coefficients From Soil Properties

Aleš Klement, Radka Kodešová, Martina Bauerová, Oksana Golovko, Martin Kočárek, Miroslav Fér, Olga Koba, Antonín Nikodem, Roman Grabic

Chemosphere. 2018 Mar;195:615-623.

PMID: 29287270

1

The New Angiotensin II Receptor Antagonist, Irbesartan: Pharmacokinetic and Pharmacodynamic Considerations

H R Brunner

Am J Hypertens. 1997 Dec;10(12 Pt 2):311S-317S.

PMID: 9438775

1

Xiaokeping Mixture Attenuates Diabetic Kidney Disease by Modulating TGF- β/Smad Pathway in db/db Mice

Bo Yang, Zhongni Xia, Chuanwei Xin, Chenggang Ma, Feng Zhang

Evid Based Complement Alternat Med. 2019 Oct 8;2019:9241896.

PMID: 31687039

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode